Hui Tian brings over 25 years of drug discovery experience across biologics, small molecules, antibodies, and peptide therapeutics, having led more than a dozen programs from target to clinic across metabolic disease, retinal disease, and oncology. As a founding scientist at NGM Biopharmaceuticals for 14 years, he helped build the company from early discovery into a multi-program clinical-stage company, giving him unusually deep hands-on experience in company building that distinguishes him from other venture investors.